BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2177953)

  • 1. Osteocalcin secretion by the human osteosarcoma cell line MG-63.
    Lajeunesse D; Frondoza C; Schoffield B; Sacktor B
    J Bone Miner Res; 1990 Sep; 5(9):915-22. PubMed ID: 2177953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
    Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
    J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63.
    Lajeunesse D; Kiebzak GM; Frondoza C; Sacktor B
    Bone Miner; 1991 Sep; 14(3):237-50. PubMed ID: 1657256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: relationship to adenylate cyclase activation.
    Titus L; Jackson E; Nanes MS; Rubin JE; Catherwood BD
    J Bone Miner Res; 1991 Jun; 6(6):631-7. PubMed ID: 1653516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the regulation of insulin-like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro.
    Nakao Y; Hilliker S; Baylink DJ; Mohan S
    J Bone Miner Res; 1994 Jun; 9(6):865-72. PubMed ID: 7521561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
    Inaba M; Terada M; Koyama H; Yoshida O; Ishimura E; Kawagishi T; Okuno Y; Nishizawa Y; Otani S; Morii H
    J Bone Miner Res; 1995 Jul; 10(7):1050-6. PubMed ID: 7484280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 17 beta-estradiol on the human osteosarcoma cell line MG-63.
    Lajeunesse D
    Bone Miner; 1994 Jan; 24(1):1-16. PubMed ID: 8186730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human osteoblastic osteosarcoma cell line (SAOS-2) with high bone alkaline phosphatase activity.
    Murray E; Provvedini D; Curran D; Catherwood B; Sussman H; Manolagas S
    J Bone Miner Res; 1987 Jun; 2(3):231-8. PubMed ID: 2843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
    Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newly established human osteosarcoma cell line with osteoblastic properties.
    Kawai A
    Clin Orthop Relat Res; 1990 Oct; (259):256-67. PubMed ID: 2170070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells.
    Wong MM; Rao LG; Ly H; Hamilton L; Tong J; Sturtridge W; McBroom R; Aubin JE; Murray TM
    J Bone Miner Res; 1990 Aug; 5(8):803-13. PubMed ID: 2173356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption.
    Lau KH; Wang SP; Linkhart TA; Demarest KT; Baylink DJ
    J Bone Miner Res; 1994 May; 9(5):695-703. PubMed ID: 8053399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with low doses of norethindrone potentiates the osteogenic effects of fluoride on human osteosarcoma cells.
    Takada J; Baylink DJ; Lau KH
    J Bone Miner Res; 1995 Oct; 10(10):1512-22. PubMed ID: 8686507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid receptors and actions in subpopulations of cultured rat bone cells. Mechanism of dexamethasone potentiation of parathyroid hormone-stimulated cyclic AMP production.
    Chen TL; Feldman D
    J Clin Invest; 1979 Apr; 63(4):750-8. PubMed ID: 220282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of alkaline phosphatase by 1,25-dihydroxyvitamin D3 and ascorbic acid in bone-derived cells.
    Franceschi RT; Young J
    J Bone Miner Res; 1990 Nov; 5(11):1157-67. PubMed ID: 1702922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that stimulation of 1,25(OH)2D3 production in primary cultures of mouse kidney cells by cyclic AMP requires new protein synthesis.
    Korkor AB; Gray RW; Henry HL; Kleinman JG; Blumenthal SS; Garancis JC
    J Bone Miner Res; 1987 Dec; 2(6):517-24. PubMed ID: 2458676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
    Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta enhances calcitonin-induced cyclic AMP production and the number of calcitonin receptors in long-term cultures of human umbilical cord blood monocytes in the presence of 1,25-dihydroxycholecalciferol.
    Mbalaviele G; Orcel P; Bouizar Z; Jullienne A; De Vernejoul MC
    J Cell Physiol; 1992 Sep; 152(3):486-93. PubMed ID: 1324244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
    Koga M; Eisman JA; Sutherland RL
    Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.